NCT02123108 Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation Status COMPLETED Phase PHASE4
NCT02109913 Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane Status UNKNOWN Phase NA
NCT02106832 Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) Status COMPLETED Phase PHASE3
NCT02099149 Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days Status WITHDRAWN Phase N/A
NCT02093325 A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia Status UNKNOWN Phase PHASE3
NCT02086513 Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT Status TERMINATED Phase PHASE1
NCT02086487 Efficacy and Safety Assessment of NIlotinib in CML Patients With Suboptimal Response on Imatinib Therapy Status TERMINATED Phase PHASE4
NCT02073487 Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel Status COMPLETED Phase PHASE2
NCT02072057 Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases. Status TERMINATED Phase PHASE2
NCT02061137 Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome Status COMPLETED Phase PHASE1/PHASE2
NCT02059772 Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema Status UNKNOWN Phase PHASE4
NCT02055911 Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema Status WITHDRAWN Phase PHASE4
NCT02055690 PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT02049541 Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT02049294 Study of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis Status COMPLETED Phase PHASE2/PHASE3
NCT02048943 Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer Status WITHDRAWN Phase PHASE1